http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H066569-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-24 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C401-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00 |
| filingDate | 1992-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1994-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H066569-B1 |
| titleOfInvention | 10,19,25-Trihydroxyvitamin D compound |
| abstract | (57) Abstract: [PROBLEMS] To provide a vitamin D compound modified with ring A and triene chromophore. [Constitution] The following formula [Chemical formula 1] (Wherein R 1 , R 2 , R 3 and R 4 may be the same or different from each other and represent hydrogen or a hydroxy-protecting group). The above compound is It is used as a precursor for compounds that show high affinity for the D-receptor protein in the intestine, a property of vitamin D metabolites and their analogs. |
| priorityDate | 1983-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.